Crossbow Therapeutics vs Kite Pharma
Crossbow Therapeutics vs Kite Pharma, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Crossbow Therapeutics is on 55/100 and Kite Pharma on 66/100.
Where each one leads
Crossbow Therapeutics
- agent readiness: 45/100 against 35/100
Kite Pharma
- our overall score: 66/100 against 55/100
- domain rating: 62/100 against 25/100
- funding raised: $421M against $157M
At a glance
| Measure | Crossbow Therapeutics | Kite Pharma |
|---|---|---|
| What it is | Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes. | Biotechnology company developing and commercializing cell therapies for cancer treatment. |
| Category | Biotechnology, Pharmaceuticals, Cancer, Immunotherapy | Biotechnology, Pharmaceuticals, Oncology, Cell Therapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2021 | 2009 |
| Headquarters | Cambridge, United States | Santa Monica, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Crossbow Therapeutics | Kite Pharma |
|---|---|---|
| Employees | 40 | Not published |
| Total funding | $157M | $421M |
| Latest round | Series B | Venture |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Crossbow Therapeutics | Kite Pharma |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 66/100 |
| Traction | 56/100 | 40/100 |
| Team | 70/100 | 80/100 |
| Search visibility | 15/100 | 15/100 |
| Quality | 65/100 | 90/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (45/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 62/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Crossbow Therapeutics | Kite Pharma |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Wix | Not detected |
| Frameworks | Not detected | Tailwind CSS, Bootstrap |
| Analytics | Not detected | Google Tag Manager |
| Open source | Yes | No |
Crossbow Therapeutics vs Kite Pharma: common questions
Which is better, Crossbow Therapeutics or Kite Pharma?
On our 0-100 score Kite Pharma rates higher (66/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Crossbow Therapeutics and Kite Pharma compare on the numbers?
Crossbow Therapeutics leads on agent readiness (45/100 against 35/100). Kite Pharma leads on our overall score (66/100 against 55/100), domain rating (62/100 against 25/100), funding raised ($421M against $157M).
Read the full Crossbow Therapeutics review and pricing or the Kite Pharma review and pricing. You can also browse other Crossbow Therapeutics alternatives we track.